← 홈

혈액암 (AML/ALL)

775개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-7 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 775개
CGTBiologicstaleChinese PLA General HospitalPhase 2

Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cells (Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cells)

B Cell Leukemia; B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleNationwide Children's HospitalPhase 2

Universal donor derived CD33 CAR-NK (Universal donor derived CD33 CAR-NK)

Relapsed/Refractory AML · CD33

#CD33#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
AntibodystaleMersana TherapeuticsPhase 3

Upifitimab rilsodotin (Upifitimab rilsodotin)

High Grade Serous Ovarian Cancer; Fallopian Tube Cancer · High Grade Serous Ovarian Cancer

#HighGradeSerousOvarianCancer#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleBeijing Biostar Pharmaceuticals…Phase 2

Utidelone combined with Bevacizumab (Utidelone combined with Bevacizumab)

Non-small Cell Lung Cancer Patients with Brain Metastases · Non-small Cell Lung Cancer Patients with

#Non-smallCellLungCancerPatientsw#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstaleVor BiopharmaPhase 2

VCAR33 (VCAR33)

Leukemia, Myeloid, Acute · Leukemia, Myeloid, Acute

#LeukemiaMyeloidAcute#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 DISCONTINUED
AntibodystaleNational Cancer Institute (NCI)Phase 2

Varlilumab (Varlilumab)

Metastatic Distal Bile Duct Adenocarcinoma; Metastatic Gallbladder Carcinoma · Metastatic Distal Bile Duct Adenocarcino

#MetastaticDistalBileDuctAdenocar#Antibody#Phase2#항체#면역항체+3
효능 ORR 7%임상시험 1상태 RECRUITING
AntibodystaleCatalYm GmbHPhase 2

Visugromab (Visugromab)

Metastatic Non-Squamous Non-Small Cell Lung Cancer; Adult Solid Tumor · Metastatic Non-Squamous Non-Small Cell L

#MetastaticNon-SquamousNon-SmallC#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleCatalYm GmbHPhase 2

recommended dose for expansion (Visugromab RDE, Visugromab RDE (recommended dose for expansion))

Metastatic Non-Squamous Non-Small Cell Lung Cancer; Adult Solid Tumor · Metastatic Non-Squamous Non-Small Cell L

#MetastaticNon-SquamousNon-SmallC#Antibody#Phase2#항체#면역항체+3
효능 ORR 100%임상시험 1상태 RECRUITING
AntibodystaleXencor, Inc.Phase 2

Vudalimab + Carboplatin + Pemetrexed (Vudalimab + Carboplatin + Pemetrexed)

Nonsquamous Non-small Cell Lung Cancer · Nonsquamous Non-small Cell Lung Cancer

#NonsquamousNon-smallCellLungCanc#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleShaare Zedek Medical CenterPhase 2

Vyxeos (Vyxeos)

Leukemia, Myeloid, Acute · Leukemia, Myeloid, Acute

#LeukemiaMyeloidAcute#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 1상태 RECRUITING
ADCBiologicstaleExelixisPhase 1

XB002 (XB002)

Non Small Cell Lung Cancer; Cervical Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleMersana TherapeuticsPhase 1

XMT-1522 (XMT-1522)

Advanced Breast Cancer; Advanced Nonsmall Cell Lung Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
CGTBiologicstaleXijing HospitalPhase 1

XYF19 CAR-T cell (XYF19 CAR-T cell)

Leukemia Lymphocytic Acute (ALL) in Relapse; Leukemia Lymphocytic Acute (All) Refractory · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
AntibodystaleXencor, Inc.Phase 2

pembrolizumab (Keytruda, XmAb18087 ± Pembrolizumab)

Merkel Cell Carcinoma; Small Cell Lung Cancer · Merkel Cell Carcinoma

#MerkelCellCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleZymeworks BC Inc.Phase 1

ZW251 (ZW251)

Hepatocellular Carcinoma; Squamous Cell Non-Small Cell Lung Cancer · Hepatocellular Carcinoma

#HepatocellularCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleInstitute of Hematology & Blood…Phase 2

Zanubrutinib, Fludarabine, cyclophosphamide and rituximab (Zanubrutinib, Fludarabine, cyclophosphamide and rituximab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleInstitute of Hematology & Blood…Phase 2

Zanubrutinib, bendamustine, rituximab (Zanubrutinib, bendamustine, rituximab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleGilead SciencesPhase 2

ZIM (Zimberelimab, Zimberelimab (ZIM))

Lung Cancer; Advanced or Metastatic Non-Small-Cell Lung Cancer · Lung Cancer

#LungCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleVanderbilt-Ingram Cancer CenterPhase 1

[68Ga]Ga-ABY-025 ([68Ga]Ga-ABY-025)

Locally Advanced Cancer; Metastatic Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
CGTBiologicstaleChildren's Hospital of Fudan Un…Phase 1

alloCART-19 (alloCART-19)

ALL, Childhood B-Cell · ALL, Childhood B-Cell

#ALLChildhoodB-Cell#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE

36 / 39 페이지

← 이전다음 →